杀伤细胞免疫球蛋白样受体（KIR）配体不相容性与双份脐带血移植后复发率降低无关。 - Suppr

Suppr

超能文献

KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation.

作者信息

Garfall A, Kim H T, Sun L, Ho V T, Armand P, Koreth J, Alyea E P, Soiffer R J, Antin J H, Ritz J, Cutler C

出版信息

Bone Marrow Transplant. 2013 Jul;48(7):1000-2. doi: 10.1038/bmt.2012.272. Epub 2013 Jan 14.

DOI:10.1038/bmt.2012.272

PMID:23318536

Abstract

摘要

相似文献

KIR ligand incompatibility is not associated with relapse reduction after double umbilical cord blood transplantation.杀伤细胞免疫球蛋白样受体（KIR）配体不相容性与双份脐带血移植后复发率降低无关。

Bone Marrow Transplant. 2013 Jul;48(7):1000-2. doi: 10.1038/bmt.2012.272. Epub 2013 Jan 14.

Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?杀伤细胞免疫球蛋白样受体和 KIR 配体不相容性对无关脐带血干细胞移植后结局的影响如何？

Best Pract Res Clin Haematol. 2010 Jun;23(2):283-90. doi: 10.1016/j.beha.2010.05.005.

KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.杀伤细胞免疫球蛋白样受体（KIR）配体与血液系统恶性肿瘤无关供者造血细胞移植后复发的预测

Biol Blood Marrow Transplant. 2006 Aug;12(8):828-36. doi: 10.1016/j.bbmt.2006.04.008.

The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.缺失的杀伤细胞免疫球蛋白样受体配体在 HLA 相同的同胞来源外周血造血干细胞移植中 T 细胞充足的作用。

Biol Blood Marrow Transplant. 2010 Feb;16(2):273-80. doi: 10.1016/j.bbmt.2009.10.021. Epub 2009 Oct 24.

The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.杀伤细胞免疫球蛋白样受体（KIR）配体不相容性对无关供者移植结局的影响：来自国际血液和骨髓移植研究中心、欧洲血液和骨髓移植登记处以及荷兰登记处的报告

Biol Blood Marrow Transplant. 2006 Aug;12(8):876-84. doi: 10.1016/j.bbmt.2006.05.007.

KIR and HLA genotypes have no identifiable role in single-unit dominance following double-unit umbilical cord blood transplantation.杀伤细胞免疫球蛋白样受体（KIR）和人类白细胞抗原（HLA）基因型在双单位脐血移植后的单单位优势方面没有可识别的作用。

Bone Marrow Transplant. 2015 Jan;50(1):150-2. doi: 10.1038/bmt.2014.218. Epub 2014 Oct 13.

The impact of immunogenetics and clinical factors on the outcome of unrelated cord blood transplantation: the Milano Cord Blood Bank data.免疫遗传学和临床因素对非血缘脐血移植结局的影响：米兰脐血库数据

Transfus Apher Sci. 2010 Jun;42(3):283-8. doi: 10.1016/j.transci.2010.03.007. Epub 2010 Apr 3.

Patients benefit from the addition of KIR repertoire data to the donor selection procedure for unrelated haematopoietic stem cell transplantation.在无关供者造血干细胞移植的供者选择程序中加入杀伤细胞免疫球蛋白样受体（KIR）库数据，患者将从中受益。

Mol Immunol. 2008 Feb;45(4):981-9. doi: 10.1016/j.molimm.2007.07.040. Epub 2007 Sep 18.

Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.两种标准的降低强度预处理方案和两种不同移植物来源在血液病成人患者异基因干细胞移植中的疗效比较：一项单中心分析。

Biol Blood Marrow Transplant. 2013 Jun;19(6):934-9. doi: 10.1016/j.bbmt.2013.03.009. Epub 2013 Mar 21.

Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation.自然杀伤细胞剂量和供体杀伤细胞免疫球蛋白样受体（KIR）基因型对人类白细胞抗原相合造血干细胞移植后结局的影响

Clin Exp Immunol. 2007 Jun;148(3):520-8. doi: 10.1111/j.1365-2249.2007.03360.x.

引用本文的文献

Role of NK cells in cord blood transplantation and their enhancement by the missing ligand effect of the killer-immunoglobulin like receptor.自然杀伤细胞在脐血移植中的作用及其通过杀伤细胞免疫球蛋白样受体的缺失配体效应得到增强。

Front Genet. 2022 Oct 18;13:1041468. doi: 10.3389/fgene.2022.1041468. eCollection 2022.

Relevance of Polymorphic KIR and HLA Class I Genes in NK-Cell-Based Immunotherapies for Adult Leukemic Patients.多态性杀伤细胞免疫球蛋白样受体（KIR）和人类白细胞抗原I类（HLA-I）基因在成人白血病患者基于自然杀伤细胞（NK细胞）的免疫治疗中的相关性

Cancers (Basel). 2021 Jul 27;13(15):3767. doi: 10.3390/cancers13153767.

Use of the HLA-B leader to optimize cord blood transplantation.利用 HLA-B 启动子优化脐血移植。

Haematologica. 2021 Dec 1;106(12):3107-3114. doi: 10.3324/haematol.2020.264424.

Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy.自然杀伤细胞作为过继性癌症免疫治疗中的异基因效应细胞

Cancers (Basel). 2019 Jun 3;11(6):769. doi: 10.3390/cancers11060769.

NK cell therapy for hematologic malignancies.用于血液系统恶性肿瘤的自然杀伤细胞疗法。

Int J Hematol. 2018 Mar;107(3):262-270. doi: 10.1007/s12185-018-2407-5. Epub 2018 Jan 27.

Patients Lacking a KIR-Ligand of HLA Group C1 or C2 Have a Better Outcome after Umbilical Cord Blood Transplantation.缺乏HLA C1或C2组KIR配体的患者在脐带血移植后预后更好。

Front Immunol. 2017 Jul 13;8:810. doi: 10.3389/fimmu.2017.00810. eCollection 2017.

Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications.脐带血自然杀伤细胞、其特征及潜在临床应用

Front Immunol. 2017 Mar 23;8:329. doi: 10.3389/fimmu.2017.00329. eCollection 2017.

Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.血液系统恶性肿瘤无关供者脐血移植的最佳实践

Biol Blood Marrow Transplant. 2017 Jun;23(6):882-896. doi: 10.1016/j.bbmt.2017.03.006. Epub 2017 Mar 6.

Can we make a better match or mismatch with KIR genotyping?我们能否在KIR基因分型方面实现更好的匹配或错配？

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):106-118. doi: 10.1182/asheducation-2016.1.106.

Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI).杀伤细胞免疫球蛋白样受体（KIR）/人类白细胞抗原（HLA）基因组合对双份脐血移植结局的影响。代表法国骨髓移植与细胞治疗协会（SFGM-TC）和法国组织相容性与免疫遗传学协会（SFHI）开展的一项法国多中心回顾性研究结果。

Bone Marrow Transplant. 2016 Nov;51(11):1499-1503. doi: 10.1038/bmt.2016.151. Epub 2016 Jun 6.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验